[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370090-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370090-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pre-course-material-acls-algorithms-2015","Pre-Course-Material-ACLS-Algorithms-2015","","International ACLS Guidelines 2015 course notes summarize key adult resuscitation algorithms for life-threatening arrhythmias and cardiac arrest. Content covers ventricular fibrillation and pulseless ventricular tachycardia with shock-first strategy, high-quality CPR targets, ventilatory and IV/IO access steps, and drug sequencing including epinephrine and antiarrhythmics. It also provides management pathways for wide complex tachycardia, paroxysmal supraventricular tachycardia, atrial fibrillation/flutter with rate control versus cardioversion and anticoagulation timing, and electrical cardioversion setup with sedation and energy levels. Asystole confirmation and epinephrine timing are included.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pre-course-material-acls-algorithms-2015/370090/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pre-course-material-acls-algorithms-2015/370090.png","ImageObject",300,407,{"name":42,"@type":43},"Jacob","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How should ventricular fibrillation/pulseless ventricular tachycardia be managed initially?","Question",{"text":63,"@type":64},"Use a shock-first approach (1 shock) followed by high-quality CPR for 2 minutes, then rhythm and pulse check. If a defibrillator is not immediately available, start CPR first and shock as soon as possible.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"When is epinephrine given for VF/pVT, and how often?",{"text":68,"@type":64},"Give epinephrine 1 mg IV after the first or second shock if needed, with repeat dosing every 3–5 minutes.",{"name":70,"@type":61,"acceptedAnswer":71},"How are wide complex tachycardias handled when the patient is stable versus unstable?",{"text":72,"@type":64},"Assess ABCs if stable, obtain oxygenation and monitoring data (history/exam/ECG/CXR), and recognize most wide complex tachycardias are VT. For unstable patients, consider cardioversion first rather than relying on medications, since drugs revert VT only about 30% of the time.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370090,1790240699,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":108,"slug":109},7,40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},8,"Research & Report",30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":107,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146},962084931830,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","International ACLS Guidelines 2015 updated November 2015/Feb 2017  \nVentricular Fibrillation/ Pulseless Ventricular Tachycardia  \nSHOCK FIRST x 1  \n(If defibrillator not immediately available start CPR then shock ASAP)  \n200 J Biphasic, 360 J Monophasic  \n↓  \nHigh Quality CPR* x 2 min  \n(then rhythm and pulse check)  \n(Ventilate, IV/IO Access)  \n↓  \nSHOCK  \n↓  \nCPR x 2 min  \n(Intubate, Drugs-give during CPR)  \nTreat reversible causes  \n↓  \n\n| EPINEPHRINE 1 mg IV (may be given after 1st or 2nd shock) \u003Cbr>(REPEAT Q 3-5 MIN)\u003Cbr>↓ |  |\n| --- | --- |\n| SHOCK |  |\n| ↓ |  |\n| CPR x 2 min |  |\n| AMIODARONE 300 mg IV bolus (Preferred)\u003Cbr>(may give 2nd dose 150 mg IV) |  |\n| If Refractory VF: |  |\n| LIDOCAINE 1.5 mg/kg IV |  |\n| (REPEAT in 3-5 min) (Max. 3 mg/kg) |  |\n| If Polymorphic VT: MAGNESIUM SULFATE 2 G IV |  |\n| ↓\u003Cbr>SHOCK  |  |\n\n*High Quality CPR: Push hard (2-2.4 inches) and fast (100-120/min), complete chest recoil, minimize interruptions, avoid excessive ventilations (10/min), change compressors q2min, monitor end-tidal C02  \nTargeted Temperature Management (32-36ºC) recommended for resuscitated v. fib. patients who remain comatose and intubated with a BP >90.  \nTreat Reversible Causes: hypovolemia, hypoxia, acidosis, K, hypothermia, toxins,  \nischemia  \nInternational ACLS Guidelines 2015  \nWIDE COMPLEX TACHYCARDIA (Likely VT)  \nASSESS ABC’S IF STABLE, O2, MONITOR, O2 SAT, VITALSIGNS (Hx, P/E, ECG, CXR)  \nAlmost all Wide Complex Tachycardias are VT (85-95%)  \nUnstable  Stable  \n(Chest pain, SOB, LOC, low BP, CHF, AMI) (consider cardioversion first, as meds only revert  \nVT 30% of the time)  \nProcainamide  \n20-50 mg/min (max 17mgkg)  \nOR  \nAmiodarone 150 mg over 10 min (repeat x2 prn)  \nInfusion: 1 mg/min x 6 hrs, then 0.5 mg/min over 24 hrs (Max: 2.2m in 24 hrs)  \nAdenosine should rarely be used for wide complex tach but may be considered if regular and monomorphic and of uncertain origin.  \nPrepare for cardioversion Consider premedication  \nSYNCHRONIZED CARDIOVERSION  \nBiphasic: 100-150-200  \nMonophasic: 200–300–360  \nIf Ventricular Tachycardia is polymorphic (Torsades) consider: magnesium 2 gm, overdrive pacing, isoproterenol, Phenytoin, Lidocaine, amiodorone.  \n*Avoid giving multiple antidysrhythmics sequentially (to prevent proarrhythmias) . If one antidysrhythmic fails, go to electrical cardioversion.  \nInternational ACLS Guidelines 2015  \nPAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA  \n(AVnRT, AVRT)  \nSTABLE  \nUNSTABLE  Unstable SVT is rare)  \nCARDIOVERSION (Consider premedication)  \nVAGAL MANOEUVRES  \nAdenosine 6 mg IV over 3 seconds, may repeat 12 mg in 1-2 min (Class I)  \n-short 10 second half life and no effects on BP  \nor Diltiazem 20 mg IV over 2 min, may repeat 25 mg IV in 15 min (Class I)  \nOther options:  \nMetoprolol 5 mg IV, may repeat x 2: max 15 mg total (Class I)  \nor Verapamil 2.5 – 5 MG I.V. over 2 min, may repeat 5-10 mg in 10 minutes (Class I)  \nOthers to consider:  \nProcainamide 30mg/min to 17/kg (Class IIa)  \nAmiodarone 150 mg over 10 min (Class IIa)  \nor  \nSYNCHRONIZED CARDIOVERSION (with premedication) Monophasic:,100,200,300 j  \nBiphasic: 70, 100, 150 j  \nInternational ACLS Guidelines 2015  \nAtrial Fibrillation or Atrial Flutter *  \nSTABLE  \n1) Control Heart Rate if > 120  \nUNSTABLE  CARDIOVERSION  \n-higher risk of stroke if a.fib/flutter>48 hrs and patient not anticoagulated  \nNarrow Complex  \nDiltiazem 20 mg IV  \nVerapamil 2.5-5mg IV 1 Metoprolol 5 mg IV 1 Amiodarone 150 mg over 10 min2 Digoxin 0.5 mg IV  \nWide Complex (WPW or BBB)  \nProcainamide 30 mg/min to 17mg/kg2 Amiodarone 150 mg over 10 min2  \n1) Do not use verapamil or metoprolol if LV function is known to be impaired (\u003C40%) .  \n2) Do not use amiodarone or procainamide if fibrillation or flutter present for > 48 hours as these medications may convert the rhythm back to sinus.  \n2) Convert rhythm back to NSR  \n-atrial flutter \u003C 48 hours requires electrical cardioversion  \nA fib \u003C 48 hours  \nCardiovert Electrically or with Drugs  \nProcainamide (","cbCaicdCRGpro6JU","https://ap.wps.com/l/cbCaicdCRGpro6JU","pdf",79667,11,"English","# Ventricular Fibrillation / Pulseless Ventricular Tachycardia\n## Shock-first sequence and high-quality CPR\n## Drug therapy and reversible causes\n# Wide Complex Tachycardia (Likely VT)\n## Stable vs unstable approach\n## Antiarrhythmic options and cardioversion\n# Paroxysmal Supraventricular Tachycardia (AVNRT/AVRT)\n## Stable vs unstable guidance\n## Vagal maneuvers, adenosine and rate-control drugs\n## Synchronized cardioversion\n# Atrial Fibrillation / Atrial Flutter\n## Rate control and cardioversion indications\n## Anticoagulation and long-term management considerations\n# Electrical Cardioversion Algorithm\n## Indications, preparation, and sedation\n## Energy dosing by rhythm\n# Asystole\n## Confirmation, CPR continuation, access, causes\n## Epinephrine and termination of efforts","[{\"question\":\"How should ventricular fibrillation/pulseless ventricular tachycardia be managed initially?\",\"answer\":\"Use a shock-first approach (1 shock) followed by high-quality CPR for 2 minutes, then rhythm and pulse check. If a defibrillator is not immediately available, start CPR first and shock as soon as possible.\"},{\"question\":\"When is epinephrine given for VF/pVT, and how often?\",\"answer\":\"Give epinephrine 1 mg IV after the first or second shock if needed, with repeat dosing every 3–5 minutes.\"},{\"question\":\"How are wide complex tachycardias handled when the patient is stable versus unstable?\",\"answer\":\"Assess ABCs if stable, obtain oxygenation and monitoring data (history/exam/ECG/CXR), and recognize most wide complex tachycardias are VT. For unstable patients, consider cardioversion first rather than relying on medications, since drugs revert VT only about 30% of the time.\"}]","Pre-Course-Material-ACLS-Algorithms-2015 | PDF",1790186674,28]